Table 4.

Influence of BMI, duration of DM, drug therapy on lipid and lipoprotein levels.

	Total cholesterol		TGL		LDL		HDL
	Mean	p value	Mean	p value	Mean	p value	Mean	p value
BMI		0.41		0.14		0.13		0.1
<25	167.6 ± 4.6		129.4 ± 68		99.4 ± 42.1		44.6 ± 13.1
25–29.9	172.7 ± 37.1		159.3 ± 65.4		107.1 ± 29.4		39.6 ± 11
≥30	165.8 ± 37.1		158 ± 90.6		98.6 ± 29		40.3 ± 12.1
Duration of DM		0.53		0.5		0.25		0.93
<5 years	171.4 ± 39.8		160.2 ± 73.5		106.9 ± 34.7		41.1 ± 13.8
5–15 years	168.8 ± 37.8		156.3 ± 85.1		99 ± 29.1		40.5 ± 11.7
>15 years	163.3 ± 36.8		142.9 ± 73.3		102.7 ± 33		40.3 ± 10
Drug therapy		0.02*		0.08		0.02*		0.8
OHA/OHA combinations	172.4 ± 41		164.7 ± 75.8		108.2 ± 31.6		41.2 ± 13.9
Insulin alone	150.7 ± 34.3		128.8 ± 50.1		91.8 ± 28.7		40.2 ± 12.7
Insulin and oral medications	169.8 ± 35.6		153.6 ± 88.2		99.1 ± 31		40.3 ± 10.1

*P values ≤ 0.05, TGL Triglyceride, LDL Low Density Lipid, HDL High Density Lipid, BMI Body Mass Index, DM Diabetes Mellitus, OHA Oral Hypoglycemic Agent.